Members of SpinUp Lab at University of Toronto Mississauga can receive 1 month off their first lease with Excedr. Average savings of ~$10,000.
SpinUp provides support for early-stage startups working to commercialize their scientific discoveries across a wide range of fields. Its state-of-the-art wet lab and office space, located at the University of Toronto Mississauga (Canada) and completed in 2024, can accommodate up to 23 companies at a time, with access to a variety of biology and chemistry equipment, infrastructure and wraparound operational supports. A two-year SpinUp membership also includes a comprehensive programming curriculum and mentorship opportunities provided by our network of innovation ecosystem partners to prepare startups for the next steps in their entrepreneurial journeys.
Fully integrated into the University of Toronto, membership at SpinUp allows entrepreneurs to tap into the institution’s academic excellence through research partnerships with faculty and student internships. With the generous support of industry supporters like Merck and AbbVie, SpinUp’s Blue Ticket Program offers promising ventures financial support and business mentorship from industry leaders to propel the next generation of global life science innovators from Mississauga. Through its partnership with Excedr, SpinUp members can receive one month off their first equipment lease—an average savings of $10,000.
SpinUp is a purpose-built wet lab incubator providing early-stage startups affordable co-working wet lab space, equipment, infrastructure, and programming at the University of Toronto Mississauga. SpinUp helps entrepreneurs overcome the resource gap by offering high-quality wet lab space to develop and commercialize their IP. Founders can tap into the research strength of a top-20 global university and the entrepreneurial network of a top-5 institution to accelerate their scientific innovations.
This opportunity is game-changing for us. Mentorship from Merck means that we can develop this medicine and hopefully get it to patients sooner. At SpinUp, we've got potential to partner with University of Toronto researchers and work with student interns. With the resources we have, there is a very high probability that we would have this ready to go into trials during our first year at SpinUp.
Jane Lapon
Founder of Atorvia
